[HTML][HTML] Pamidronate therapy as prevention of bone loss following renal transplantation
SLS Fan, MK Almond, E Ball, K Evans… - Kidney international, 2000 - Elsevier
Pamidronate therapy as prevention of bone loss following renal transplantation. Background
Very rapid bone loss, osteopenia and skeletal morbidity after renal transplantation have …
Very rapid bone loss, osteopenia and skeletal morbidity after renal transplantation have …
Sertraline versus placebo in patients with major depressive disorder undergoing hemodialysis: a randomized, controlled feasibility trial
K Friedli, A Guirguis, M Almond, C Day… - Clinical Journal of the …, 2017 - journals.lww.com
Results In total, 709 patients were screened and enrolled between April of 2013 and October
of 2014; 231 (32.6%) had Beck Depression Inventory II scores≥ 16, and 68 (29%) of these …
of 2014; 231 (32.6%) had Beck Depression Inventory II scores≥ 16, and 68 (29%) of these …
Depression symptoms in haemodialysis patients predict all-cause mortality but not kidney transplantation: a cause-specific outcome analysis
J Chilcot, A Guirguis, K Friedli, M Almond… - Annals of Behavioral …, 2018 - academic.oup.com
Background Depression is common in haemodialysis (HD) patients and associated with
poor outcomes. Purpose To evaluate whether depression symptoms predict survival and …
poor outcomes. Purpose To evaluate whether depression symptoms predict survival and …
Postdialysis recovery time is extended in patients with greater self‐reported depression screening questionnaire scores
A Davenport, A Guirguis, M Almond… - Hemodialysis …, 2018 - Wiley Online Library
Introduction: Most patients take time to recover after a hemodialysis (HD) session. It has been
suggested that recovery time is associated with intradialytic hypotension and rapid solute …
suggested that recovery time is associated with intradialytic hypotension and rapid solute …
Evidence that self-affirmation improves phosphate control in hemodialysis patients: a pilot cluster randomized controlled trial
…, S Norton, DM Wellsted, MK Almond… - Annals of Behavioral …, 2014 - academic.oup.com
Background Hemodialysis patients are at risk of serious health complications, yet treatment
non-adherence remains high. Purpose Warnings about health risks associated with non-…
non-adherence remains high. Purpose Warnings about health risks associated with non-…
Diagnosis and management of urinary tract infection in adults.
ME Wilkie, MK Almond, FP Marsh - BMJ: British Medical Journal, 1992 - ncbi.nlm.nih.gov
Although most urinary tract infections in adults are uncomplicated and respond rapidly to
empirical antimicrobial therapy, they represent a considerable health problem, particularly …
empirical antimicrobial therapy, they represent a considerable health problem, particularly …
Beyond compliance: corruption, corporate responsibility and ethical standards in the new global economy
MA Almond, SD Syfert - NCJ Int'l L. & Com. Reg., 1996 - HeinOnline
The driving force behind the New Global Economy is international competitiveness. As
multinational enterprises struggle to meet the challenges of today's freewheeling, 24-houra-day, …
multinational enterprises struggle to meet the challenges of today's freewheeling, 24-houra-day, …
The Beck Depression Inventory requires modification in scoring before use in a haemodialysis population in the UK
D Grant, MK Almond, A Newnham, P Roberts… - Nephron Clinical …, 2008 - karger.com
Background: There are high rates of mental illness, especially depression in people with
end-stage renal disease (ESRD) on haemodialysis (HD). Depression can be difficult to …
end-stage renal disease (ESRD) on haemodialysis (HD). Depression can be difficult to …
Pharmacokinetics of bupropion and its metabolites in haemodialysis patients who smoke: A single dose study
SPR Worrall, MK Almond, S Dhillon - Nephron Clinical Practice, 2004 - karger.com
To date, no study has investigated the effects of bupropion (BP) in renal-impaired humans.
This study aims to identify the pharmacokinetics of BP and metabolites in haemodialysis …
This study aims to identify the pharmacokinetics of BP and metabolites in haemodialysis …
Scaling hemodialysis target dose to reflect body surface area, metabolic activity, and protein catabolic rate: a prospective, cross-sectional study
…, E Vilar, A Davenport, N Ashman, M Almond… - American Journal of …, 2017 - Elsevier
Background Women and small men treated by hemodialysis (HD) have reduced survival.
This may be due to use of total-body water (V) as the normalizing factor for dialysis dosing. In …
This may be due to use of total-body water (V) as the normalizing factor for dialysis dosing. In …